Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

by Balasubramanian, V.P, Bourge, R.C, Burger, C.D, Chakinala, M.M, Eggert, M.S, Elwing, J.M, Feldman, J., Hill, N.S, King, C., Klinger, J.R, Mathai, S.C, McConnell, J.W, Palevsky, H.I, Rahaghi, F.F, Restrepo-Jaramillo, R., Safdar, Z., Sager, J.S, Sood, N., Sulica, R., White, R.J
Published 2022